SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 307 filers reported holding SEATTLE GENETICS INC in Q4 2018. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $65,987,000 | +61.4% | 337,204 | +40.2% | 2.47% | +58.9% |
Q2 2020 | $40,876,000 | +65.1% | 240,559 | +12.1% | 1.56% | +39.1% |
Q1 2020 | $24,752,000 | -21.7% | 214,530 | -22.5% | 1.12% | -6.4% |
Q4 2019 | $31,623,000 | +27.7% | 276,766 | -4.5% | 1.20% | +10.7% |
Q3 2019 | $24,760,000 | +23.4% | 289,925 | 0.0% | 1.08% | +31.9% |
Q2 2019 | $20,066,000 | -5.5% | 289,925 | 0.0% | 0.82% | -5.0% |
Q1 2019 | $21,234,000 | +65.6% | 289,925 | +28.1% | 0.86% | +57.0% |
Q4 2018 | $12,819,000 | -40.5% | 226,239 | -19.0% | 0.55% | -29.8% |
Q3 2018 | $21,549,000 | +16.2% | 279,417 | 0.0% | 0.78% | +11.1% |
Q2 2018 | $18,550,000 | +2.3% | 279,417 | -19.4% | 0.70% | -0.1% |
Q1 2018 | $18,136,000 | +51.5% | 346,499 | +54.9% | 0.70% | +52.6% |
Q4 2017 | $11,968,000 | -1.7% | 223,700 | 0.0% | 0.46% | +6.2% |
Q3 2017 | $12,172,000 | +5.2% | 223,700 | 0.0% | 0.44% | +1.4% |
Q2 2017 | $11,574,000 | – | 223,700 | – | 0.43% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 45,725,556 | $2,365,840,000 | 20.68% |
Lagoda Investment Management, L.P. | 398,529 | $20,620,000 | 7.88% |
Matrix Capital Management Company, LP | 2,118,000 | $109,585,000 | 3.72% |
Ghost Tree Capital, LLC | 300,000 | $15,522,000 | 3.23% |
Sio Capital Management, LLC | 100,000 | $5,174,000 | 2.46% |
GREAT POINT PARTNERS LLC | 249,500 | $12,909,000 | 2.31% |
Redmile Group, LLC | 665,139 | $34,414,000 | 2.10% |
Eventide Asset Management | 525,000 | $27,164,000 | 1.69% |
Opus Point Partners Management, LLC | 35,093 | $1,816,000 | 1.66% |
Boxer Capital, LLC | 125,000 | $6,468,000 | 1.54% |